Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward D Ball

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Leukemia Research|November 24, 2005
Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or olderAsad Bashey, Lin Liu, Anita Ihasz, et al.
Genome Medicine|May 21, 2020
MHC-I genotype and tumor mutational burden predict response to immunotherapyAaron M Goodman, Andrea Castro, Rachel Marty Pyke, et al.
Transplantation Science|May 17, 2011
Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in ManCamillo Ricordi, Andreas G Tzakis, Anthony J Demetris, et al.
Transfusion|October 26, 2007
Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantationAsad Bashey, Michael Donohue, Lin Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemiaAndre S Jung, Peter R Holman, Januario E Castro, et al.
Blood|September 5, 2021
Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemiaAmanda G Davis, Daniel T Johnson, Dinghai Zheng, et al.
Blood|November 1, 2008
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantationAsad Bashey, Bridget Medina, Sue Corringham, et al.
Journal of Medicinal Chemistry|January 7, 2012
VX-322: a novel dual receptor tyrosine kinase inhibitor for the treatment of acute myelogenous leukemiaDavid K Heidary, George Huang, Diane Boucher, et al.
Hematology (Amsterdam, Netherlands)|July 8, 2022
Extracorporeal photopheresis for the treatment of chronic graft versus host diseaseEmin Kansu, David Ward, Amber P Sanchez, et al.
Transplantation and Cellular Therapy|October 16, 2021
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell LymphomasAaron M Goodman, Kimberly A Holden, Ah-Reum Jeong, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Leukemia Research|November 24, 2005
Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or olderAsad Bashey, Lin Liu, Anita Ihasz, et al.
Genome Medicine|May 21, 2020
MHC-I genotype and tumor mutational burden predict response to immunotherapyAaron M Goodman, Andrea Castro, Rachel Marty Pyke, et al.
Transplantation Science|May 17, 2011
Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in ManCamillo Ricordi, Andreas G Tzakis, Anthony J Demetris, et al.
Transfusion|October 26, 2007
Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantationAsad Bashey, Michael Donohue, Lin Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemiaAndre S Jung, Peter R Holman, Januario E Castro, et al.
Blood|September 5, 2021
Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemiaAmanda G Davis, Daniel T Johnson, Dinghai Zheng, et al.
Blood|November 1, 2008
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantationAsad Bashey, Bridget Medina, Sue Corringham, et al.
Journal of Medicinal Chemistry|January 7, 2012
VX-322: a novel dual receptor tyrosine kinase inhibitor for the treatment of acute myelogenous leukemiaDavid K Heidary, George Huang, Diane Boucher, et al.
Hematology (Amsterdam, Netherlands)|July 8, 2022
Extracorporeal photopheresis for the treatment of chronic graft versus host diseaseEmin Kansu, David Ward, Amber P Sanchez, et al.
Transplantation and Cellular Therapy|October 16, 2021
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell LymphomasAaron M Goodman, Kimberly A Holden, Ah-Reum Jeong, et al.
Pageof 7